Cargando…

Quality of Life Outcomes and Associated Symptoms Reported by Lung Transplant Recipients Amidst COVID-19 Pandemic: Applying a Novel Assessment Tool

BACKGROUND: There are 2 main aims of lung transplantation for people with end-stage lung disease: (1) to extend life and (2) to improve its quality. Much consideration is given to how to support the longevity and functioning of the allograft, though less robust studies have been done on the quality...

Descripción completa

Detalles Bibliográficos
Autores principales: Storaasli, Sasha, Nakagawa, Shunichi, Singer, Jonathan P., Fedoronko, David A., Zhang, Yuan, Tsapepas, Demetra, Rincon, Maylin E., Scheffert, Jenna, Benvenuto, Luke, Arcasoy, Selim M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271457/
https://www.ncbi.nlm.nih.gov/pubmed/35940947
http://dx.doi.org/10.1016/j.transproceed.2022.07.001
_version_ 1784744683870617600
author Storaasli, Sasha
Nakagawa, Shunichi
Singer, Jonathan P.
Fedoronko, David A.
Zhang, Yuan
Tsapepas, Demetra
Rincon, Maylin E.
Scheffert, Jenna
Benvenuto, Luke
Arcasoy, Selim M.
author_facet Storaasli, Sasha
Nakagawa, Shunichi
Singer, Jonathan P.
Fedoronko, David A.
Zhang, Yuan
Tsapepas, Demetra
Rincon, Maylin E.
Scheffert, Jenna
Benvenuto, Luke
Arcasoy, Selim M.
author_sort Storaasli, Sasha
collection PubMed
description BACKGROUND: There are 2 main aims of lung transplantation for people with end-stage lung disease: (1) to extend life and (2) to improve its quality. Much consideration is given to how to support the longevity and functioning of the allograft, though less robust studies have been done on the quality of the recipients’ lives. With an interest in providing compassionate and holistic patient-centered care, it is vital that the treatment providers accurately understand their patients’ lived experience. This study aimed to describe the health-related quality of life experiences of lung transplant recipients. An interest was held for where patients may struggle, thus informing where support might be needed to achieve the best possible outcomes. METHODS: This single-center study used a validated Lung Transplant Quality of Life questionnaire, which was sent in autumn of 2020 to all of the lung transplant recipients (n = 581) under the care of Columbia University Irving Medical Center (New York, NY). RESULTS: “Anxiety/Depression” had the highest concentration of struggle responses, followed closely by “Pulmonary Symptoms” and “Neuromuscular Symptoms.” “Neuromuscular Problems” and “Sexual Problems” had the highest percentage of struggle responses. As the struggles increased, the overall quality of life rating dropped proportionately. There was no correlation between the overall quality of life and graft dysfunction, age, or time out from transplant date. All of the domains held an average rating of "Satisfactory,” except “Treatment Burden,” which was rated as “Favorable.” Those ratings dropped for the cohort of patients who died during the study period. CONCLUSIONS: With the goal of providing comprehensive care at the forefront of transplant priorities, we found the newly developed questionnaire invaluable in targeting areas for quality improvements, mostly notably respecting recipient mental health.
format Online
Article
Text
id pubmed-9271457
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-92714572022-07-11 Quality of Life Outcomes and Associated Symptoms Reported by Lung Transplant Recipients Amidst COVID-19 Pandemic: Applying a Novel Assessment Tool Storaasli, Sasha Nakagawa, Shunichi Singer, Jonathan P. Fedoronko, David A. Zhang, Yuan Tsapepas, Demetra Rincon, Maylin E. Scheffert, Jenna Benvenuto, Luke Arcasoy, Selim M. Transplant Proc Article BACKGROUND: There are 2 main aims of lung transplantation for people with end-stage lung disease: (1) to extend life and (2) to improve its quality. Much consideration is given to how to support the longevity and functioning of the allograft, though less robust studies have been done on the quality of the recipients’ lives. With an interest in providing compassionate and holistic patient-centered care, it is vital that the treatment providers accurately understand their patients’ lived experience. This study aimed to describe the health-related quality of life experiences of lung transplant recipients. An interest was held for where patients may struggle, thus informing where support might be needed to achieve the best possible outcomes. METHODS: This single-center study used a validated Lung Transplant Quality of Life questionnaire, which was sent in autumn of 2020 to all of the lung transplant recipients (n = 581) under the care of Columbia University Irving Medical Center (New York, NY). RESULTS: “Anxiety/Depression” had the highest concentration of struggle responses, followed closely by “Pulmonary Symptoms” and “Neuromuscular Symptoms.” “Neuromuscular Problems” and “Sexual Problems” had the highest percentage of struggle responses. As the struggles increased, the overall quality of life rating dropped proportionately. There was no correlation between the overall quality of life and graft dysfunction, age, or time out from transplant date. All of the domains held an average rating of "Satisfactory,” except “Treatment Burden,” which was rated as “Favorable.” Those ratings dropped for the cohort of patients who died during the study period. CONCLUSIONS: With the goal of providing comprehensive care at the forefront of transplant priorities, we found the newly developed questionnaire invaluable in targeting areas for quality improvements, mostly notably respecting recipient mental health. Elsevier Inc. 2022-12 2022-07-11 /pmc/articles/PMC9271457/ /pubmed/35940947 http://dx.doi.org/10.1016/j.transproceed.2022.07.001 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Storaasli, Sasha
Nakagawa, Shunichi
Singer, Jonathan P.
Fedoronko, David A.
Zhang, Yuan
Tsapepas, Demetra
Rincon, Maylin E.
Scheffert, Jenna
Benvenuto, Luke
Arcasoy, Selim M.
Quality of Life Outcomes and Associated Symptoms Reported by Lung Transplant Recipients Amidst COVID-19 Pandemic: Applying a Novel Assessment Tool
title Quality of Life Outcomes and Associated Symptoms Reported by Lung Transplant Recipients Amidst COVID-19 Pandemic: Applying a Novel Assessment Tool
title_full Quality of Life Outcomes and Associated Symptoms Reported by Lung Transplant Recipients Amidst COVID-19 Pandemic: Applying a Novel Assessment Tool
title_fullStr Quality of Life Outcomes and Associated Symptoms Reported by Lung Transplant Recipients Amidst COVID-19 Pandemic: Applying a Novel Assessment Tool
title_full_unstemmed Quality of Life Outcomes and Associated Symptoms Reported by Lung Transplant Recipients Amidst COVID-19 Pandemic: Applying a Novel Assessment Tool
title_short Quality of Life Outcomes and Associated Symptoms Reported by Lung Transplant Recipients Amidst COVID-19 Pandemic: Applying a Novel Assessment Tool
title_sort quality of life outcomes and associated symptoms reported by lung transplant recipients amidst covid-19 pandemic: applying a novel assessment tool
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271457/
https://www.ncbi.nlm.nih.gov/pubmed/35940947
http://dx.doi.org/10.1016/j.transproceed.2022.07.001
work_keys_str_mv AT storaaslisasha qualityoflifeoutcomesandassociatedsymptomsreportedbylungtransplantrecipientsamidstcovid19pandemicapplyinganovelassessmenttool
AT nakagawashunichi qualityoflifeoutcomesandassociatedsymptomsreportedbylungtransplantrecipientsamidstcovid19pandemicapplyinganovelassessmenttool
AT singerjonathanp qualityoflifeoutcomesandassociatedsymptomsreportedbylungtransplantrecipientsamidstcovid19pandemicapplyinganovelassessmenttool
AT fedoronkodavida qualityoflifeoutcomesandassociatedsymptomsreportedbylungtransplantrecipientsamidstcovid19pandemicapplyinganovelassessmenttool
AT zhangyuan qualityoflifeoutcomesandassociatedsymptomsreportedbylungtransplantrecipientsamidstcovid19pandemicapplyinganovelassessmenttool
AT tsapepasdemetra qualityoflifeoutcomesandassociatedsymptomsreportedbylungtransplantrecipientsamidstcovid19pandemicapplyinganovelassessmenttool
AT rinconmayline qualityoflifeoutcomesandassociatedsymptomsreportedbylungtransplantrecipientsamidstcovid19pandemicapplyinganovelassessmenttool
AT scheffertjenna qualityoflifeoutcomesandassociatedsymptomsreportedbylungtransplantrecipientsamidstcovid19pandemicapplyinganovelassessmenttool
AT benvenutoluke qualityoflifeoutcomesandassociatedsymptomsreportedbylungtransplantrecipientsamidstcovid19pandemicapplyinganovelassessmenttool
AT arcasoyselimm qualityoflifeoutcomesandassociatedsymptomsreportedbylungtransplantrecipientsamidstcovid19pandemicapplyinganovelassessmenttool